Carlos H. Barrios

机构：Centro Brasileiro de Estudos em Dermatologia · ORCID：0000-0001-6021-667X

发表论文 510 篇 · 总被引 66731 次 · h-index 89

代表论文

• Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer (2025 · New England Journal of Medicine · 被引 70)
• Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025 · ESMO Open · 被引 36)
• Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ ERBB2 -Negative Early Breast Cancer (2025 · JAMA Oncology · 被引 21)
• Final analysis of nivolumab plus cabozantinib for advanced renal cell carcinoma from the randomized phase III CheckMate 9ER trial (2025 · Annals of Oncology · 被引 20)
• Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial (2025 · Diabetes Care · 被引 8)
• Challenges and Opportunities for Cancer Clinical Trials Development in Latin America (2025 · JCO Global Oncology · 被引 2)